Ginkgetin enhances breast cancer radiotherapy sensitization by suppressing NRF2-HO-1 axis activity
Toxicology and Applied Pharmacology, Journal Year: 2024, Volume and Issue: 495, P. 117199 - 117199
Published: Dec. 8, 2024
Language: Английский